Genprex, Inc. Addresses Nasdaq Minimum Stockholders' Equity Requirement

Genprex, Inc. previously received a notice from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market. The company was granted an exception until December 31, 2025, to demonstrate compliance. Following recent registered direct offerings, utilization of an at-the-market offering, and an equity line of credit, Genprex believes it now exceeds the required stockholders' equity. However, Nasdaq’s Hearings Panel has not yet made a final determination on the company’s compliance status. Therefore, there is no guarantee that Genprex’s common stock will remain listed on the Nasdaq Capital Market until the Panel officially confirms compliance with all listing standards.